JAGX - ジャガ―・アニマル・ヘルス （Jaguar Health Inc.） ジャガ―・アニマル・ヘルスJAGXのチャート
JAGXの企業情報
| symbol | JAGx |
|---|---|
| 会社名 | Jaguar Animal Health Inc （ジャガ―・アニマル・ヘルス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 ジャガー・ヘルス(Jaguar Health Inc.)（旧名:Jaguar Animal Health Inc.）は天然製品医薬品会社である。同社は人の処方箋使用及び動物のためのグローバルで、新規で持続可能な派生の消化器製品の開発及び製品化に従事する。Napo Pharmaceuticals Inc.を通じて、伝統的に熱帯雨林地域で使用される植物から、世界市場向けに独自のヒト胃腸薬を開発・商品化することを行う。Mytesiは、抗レトロウィルス療法に対するヒト免疫不全ウイルスHIV /後天性免疫不全症候群（AIDS）を有する成人患者における非感染性下痢の症候性軽減のために示される抗下痢剤である。他の製品はCanalevia、Equilevia、Neonorm Calf及びNeonorm Foalを含む。 ジャガ―・アニマル・ヘルスは米国の動物用医薬品メ―カ―。ペットや生産動物用の胃腸用治療薬の開発や商品化に焦点を当てる。主な薬品候補には、犬用の水溶性下痢治療処方薬「Canalevia」がある。また、非処方箋薬として、離乳前の酪農子牛用の水溶性下痢治療薬「Neonorm」を開発。本社はサンフランシスコ。 Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. Its Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy and the only oral plant-based prescription medicine approved under FDA Botanical Guidance. |
| 本社所在地 | 201 Mission Street Suite 2375 San Francisco CA 94105 USA |
| 代表者氏名 | James J. Bochnowski ジェームズJ.ボノフノキ |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 415-896-5081 |
| 設立年月日 | 41426 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2015年 |
| 従業員数 | － |
| url | https://jaguar.health/ |
| nasdaq_url | https://www.nasdaq.com/symbol/jagx |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -19.94703 |
| 終値（lastsale） | 0.5701 |
| 時価総額（marketcap） | 28407706.734 |
| 時価総額 | 時価総額（百万ドル） 14.40071 |
| 売上高 | 売上高（百万ドル） 4.33046 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 36.40752 |
| 当期純利益 | 当期純利益（百万ドル） -29.79644 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Jaguar Health Inc revenues decreased 2% to $1.7M. Net loss applicable to common stockholders increased from $6.5M to $14.3M. Revenues reflect Collaboration revenue decrease of 89% to $177K. Higher net loss reflects Sales and marketing expense increase from $280K to $4.4M (expense) Interest expense increase from $336K to $1.3M (expense) General and administrative expense increase of 11% to $6.1M (expense). |
JAGXのテクニカル分析
JAGXのニュース
Jaguar Health Inc. (JAGX) did well last session? 2023/03/06 16:00:00 US Post News
As of Friday, Jaguar Health Inc.’s (NASDAQ:JAGX) stock closed at $1.57, down from $1.67 the previous day. While Jaguar Health Inc. has underperformed by -5.99%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, JAGX fell by -95.24%, with highs and lows ranging from $61.12 to $1.60, […]
Unlocking Growth Opportunity In Jaguar Health Inc. (NASDAQ: JAGX) 2023/02/24 14:30:00 Stocks Register
Jaguar Health Inc. (NASDAQ:JAGX) price on Thursday, February 23, fall -5.86% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.41. A look at the stock’s price movement, the close in the last trading session was $2.56, moving within a range at $2.37 and $2.70. The beta value … Unlocking Growth Opportunity In Jaguar Health Inc. (NASDAQ: JAGX) Read More »
Current Sizzling Stocks Alert: Jaguar Health, Inc. (NASDAQ:JAGX), TherapeuticsMD, Inc. (NASDAQ:TXMD) 2023/02/23 15:42:10 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Current Sizzling Stocks Alert: Jaguar Health, Inc. (NASDAQ:JAGX), TherapeuticsMD, Inc. (NASDAQ:TXMD) appeared first on Stocks Equity .
JAGX stock spikes on patent win for antidiarrheal therapy (NASDAQ:JAGX) 2023/02/23 14:29:02 Seeking Alpha
Jaguar Health (JAGX) added ~7% pre-market Thursday after announcing a U.S. patent win related to its FDA-authorized antidiarrheal therapy Crofelemer. Read the full story here.
Jaguar Health, Inc.: Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer 2023/02/23 13:38:00 Finanz Nachrichten
Company''s IP estate includes approximately 200 patents issued and pendingSAN FRANCISCO, CA / ACCESSWIRE / February 23, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today ann…
Jaguar Animal Health Co-Sponsoring Closing Ceremony at Veterinary Cancer Society Annual Conference on October 15th to Drive Awareness of Jaguar''s Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) Initiative - Stocks News Feed 2022/10/12 12:43:41 Stocks News Feed
Conference attendees are invited to visit Jaguar Animal Health’s exhibit booth to take part in a Take C.H.A.R.G.E. Spin the Wheel promotion for a chance to win an original painting made with the latex from the Croton lechleri tree SAN FRANCISCO, CA / ACCESSWIRE / October 12, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced… Read More »Jaguar Animal Health Co-Sponsoring Closing Ceremony at Veterinary Cancer Society Annual Conference on October 15th to Drive Awareness of Jaguar’s Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) Initiative
Jaguar Health, Inc.: Jaguar Animal Health Co-Sponsoring Closing Ceremony at Veterinary Cancer Society Annual Conference on October 15th to Drive Awareness of Jaguar''s Take C.H.A.R.G.E. Initiative 2022/10/12 12:32:00 Finanz Nachrichten
Conference attendees are invited to visit Jaguar Animal Health''s exhibit booth to take part in a Take C.H.A.R.G.E. Spin the Wheel promotion for a chance to win an original painting made with the la…
Jaguar Animal Health Co-Sponsoring Closing Ceremony at Veterinary Cancer Society Annual Conference on October 15th to Drive Awareness of Jaguar''s Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) Initiative 2022/10/12 12:30:00 Accesswire
Conference attendees are invited to visit Jaguar Animal Health''s exhibit booth to take part in a Take C.H.A.R.G.E. Spin the Wheel promotion for a chance to win an original painting made with the latex from the Croton lechleri tree SAN FRANCISCO, CA / ACCESSWIRE / October 12, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company, under its Jaguar Animal Health tradename for the veterinary market, is co-sponsoring the Closing Ceremony at the Veterinary Cancer Society (VCS) Annual Conference to drive awareness of Jaguar''s Take C.H.A.R.G.E. ( C anine H ealth A nd R e G istry E xchange) initiative. The Closing Ceremony takes place from 6:30 PM - 10:00 PM Eastern Time on Saturday, October 15, 2022 at the conference, which runs October 13-15 in Norfolk, Virginia. The Take C.H.A.R.G.E. registry is the first U.S.-based national cancer registry tracking the incidence and prevalence of cancer in dogs. Information on the impact of canine cancer by breed, type, age, gender, and location is provided on an open access, easy to use, interactive dashboard .
Can you now get a good deal on Jaguar Health Inc.’s shares? 2022/10/03 14:54:00 US Post News
Jaguar Health Inc. (NASDAQ:JAGX) closed Friday at $0.16 per share, down from $0.16 a day earlier. While Jaguar Health Inc. has underperformed by -2.92%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, JAGX fell by -93.13%, with highs and lows ranging from $2.66 to $0.15, whereas […]
Jaguar Health, Inc.: Jaguar Health Subsidiary Napo Pharmaceuticals Announces Activation by FDA of Investigational New Drug Application for NP-300, a Novel Drug Candidate for the Symptomatic Relief and Treatment of Diarrhea from Cholera and Other Pathogens 2022/09/29 12:32:00 Finanz Nachrichten
SAN FRANCISCO, CA / ACCESSWIRE / September 29, 2022 / Napo Pharmaceuticals, Inc. ("Napo"), the wholly-owned subsidiary of Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announc…
Jaguar Health''s Italian firm applies for orphan drug designation for crofelemer to EMA 2022/05/25 13:26:56 Seeking Alpha
Jaguar Health (JAGX) said on Wednesday its Italian firm Napo Therapeutics had submitted an Orphan Drug Designation application for crofelemer to treat a rare congenital diarrhea…
Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index 2022/05/23 11:00:00 Jaguar Health
"Canine Cancer: Take C.H.A.R.G.E." (Canine Health And ReGistry Exchange) Based on Nationwide Gallup Poll of Pet Owners and Initial Assessment of More Than 35,000 Canine Medical Records Initial Data from Gallup Poll of More Than 3,500 Dog Owners Suggest Nearly Five-Fold Greater Incidence of Canine
Jaguar Health GAAP EPS of -$0.40 misses by $0.23, revenue of $2.62M beats by $1M 2022/05/10 12:03:47 Seeking Alpha
Jaguar Health press release (JAGX): Q1 GAAP EPS of -$0.40 misses by $0.23.Non-GAAP EBITDA for the first quarter of 2022 and the first quarter of 2021 was a net loss of $9.4 million…
Jaguar Health Q1 2022 Earnings Preview 2022/05/09 16:45:59 Seeking Alpha
Jaguar Health (JAGX) is scheduled to announce Q1 earnings results on Tuesday, May 10th, before market open.The consensus EPS Estimate is -$0.18 (-80.0% Y/Y) and the consensus…
Jaguar Health Inc. (NASDAQ: JAGX) Slid -5.45% In 6 Months Getting Ready For What’s Next 2022/05/07 20:00:00 Marketing Sentinel
Jaguar Health Inc. (NASDAQ:JAGX)’s traded shares stood at 0.7 million during the last session, with the company’s beta value hitting 1.82. At the close of trading, the stock’s price was $0.42, to imply a decrease of -5.28% or -$0.03 in intraday trading. The JAGX share’s 52-week high remains $6.84, putting it -1528.57% down since that … Jaguar Health Inc. (NASDAQ: JAGX) Slid -5.45% In 6 Months Getting Ready For What’s Next Read More »